.Merck defeats revenues requirements, increases purchases outlook on tough requirement for best medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Forecasts as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Sturdy End Results, But Outlook Tumbles Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings and also sales desires in the middle of Keytruda advantage, yet delivers blended full-year overview MarketWatch.